Related Experiment Videos
Diagnostic biochip array for fast and sensitive detection of K-ras mutations in stool
Lothar Prix1, Peter Uciechowski, Beatrix Böckmann
1Institut für Molekulare NanoTechnologie, Berghäuser Strasse 295, 45659 Recklinghausen, Germany.
Clinical Chemistry
|February 28, 2002
Summary
A new K-ras biochip test accurately detects common mutations in stool samples, aiding early colon cancer screening. This rapid molecular screening method offers high sensitivity and specificity for tumor cell detection.
Area of Science:
- Molecular Biology
- Oncology
- Biotechnology
Background:
- Tumor cells shed into stool are valuable for early detection of colon and pancreatic cancers.
- Developing sensitive molecular screening tests is crucial for early cancer diagnosis.
Purpose of the Study:
- To develop and validate a novel diagnostic test for detecting common K-ras gene mutations (codons 12 and 13) in stool samples.
- To assess the efficacy of a new biochip array technology for rapid K-ras mutation screening.
Main Methods:
- DNA extraction from stool samples followed by Peptide Nucleic Acid (PNA)-mediated PCR clamping for mutant-specific amplification.
- Utilized a biochip with immobilized oligonucleotides for hybridization-based K-ras mutation detection.
- Biochip readout via confocal time-resolved laser scanning, with analysis completed in under 2 hours.
Main Results:
- The K-ras biochip demonstrated high sensitivity, detecting mutations in the presence of a 1000-fold excess of wild-type DNA.
- Achieved high discrimination ratios (>19) between different K-ras mutations.
- Analysis of 26 stool samples confirmed 9 mutations via biochip hybridization, all validated by sequencing; PNA-PCR and restriction assays showed lower accuracy.
Conclusions:
- The K-ras biochip is a highly effective tool for rapid and accurate mutation detection in stool specimens.
- This technology shows significant promise for improving early colorectal cancer screening through molecular analysis of shed tumor cells.